An ancient conflict between hosts and pathogens has driven the innate and adaptive arms of
immunity. Knowledge about this interplay can not only help us identify biological …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to COVID-19 and has
become a pandemic worldwide with mortality of millions. Nanotechnology can be used to …

A proportion of patients surviving acute coronavirus disease 2019 (COVID-19) infection
develop post-acute COVID syndrome (long COVID (LC)) lasting longer than 12 weeks. Here …

Phthalates (PAEs) are known environmental endocrine disruptors that have been widely
detected in several environments, and many studies have reported the immunotoxic effects …

The continuous emergence of infectious pathogens along with antimicrobial resistance
creates a need for an alternative approach to treat infectious diseases. Targeting host factor …

Although significant research has been done to find effective drugs against coronavirus
disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 …

Abstract Coronavirus disease (COVID-19) is a viral infectious disease caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. The infection was reported in …

Although frequently reported since the beginning of the pandemic, questions remain
regarding the impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) …

Novel therapies for the treatment of COVID-19 are continuing to emerge as the SARS-Cov-2
pandemic progresses. PCR remains the standard benchmark for initial diagnosis of COVID …

The corona virus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome
coronavirus type 2 (SARS‐COV‐2) poses a severe threat to human health and still spreads …